OKYO Pharma Limited (OKYO) Earnings History
Annual and quarterly earnings data from 2008 to 2025
Loading earnings history...
OKYO EPS Growth (CAGR)
Compound annual growth rate of diluted earnings per share
CAGR (Compound Annual Growth Rate) shows the annualized growth rate of EPS over the specified period. A higher CAGR indicates stronger earnings momentum.
OKYO Profitability Analysis
Margin trends over time
| Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| 2025 | - | - | - |
| 2024 | - | - | - |
| 2023 | - | - | - |
| 2022 | - | - | - |
| 2021 | - | - | - |
Download Data
Export OKYO earnings history in CSV or JSON format
Free sign-in required to download data
OKYO Pharma Limited (OKYO) Earnings Overview
As of May 8, 2026, OKYO Pharma Limited (OKYO) reported trailing twelve-month net income of -$5M. The company earned $-0.12 per diluted share over the past four quarters.
Looking at the long-term picture, OKYO's historical earnings data spans multiple years. The company achieved its highest annual net income of $14M in fiscal 2009.
OKYO Pharma Limited is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to peers including LNTH ($279M net income, 15.2% margin), NVCR (-$173M net income, -20.8% margin), SGHT (-$37M net income, -49.7% margin), OKYO has comparable earnings metrics. Compare OKYO vs LNTH →
OKYO Earnings vs Peers
Earnings metrics vs comparable public companies
OKYO Historical Earnings Data (2008–2025)
18 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | -$5M | +72.0% | -$7M | $-0.12 | - | - |
| 2024 | -$17M | -26.8% | -$16M | $-0.00 | - | - |
| 2023 | -$13M | -144.4% | -$13M | $-0.60 | - | - |
| 2022 | -$5M | -61.9% | -$6M | $-0.36 | - | - |
| 2021 | -$3M | -117.5% | -$4M | $-0.32 | - | - |
| 2020 | -$2M | +68.5% | -$2M | $-0.17 | - | - |
| 2019 | -$5M | +82.7% | -$5M | $-0.62 | - | - |
| 2018 | -$28M | -11545.7% | -$28M | $-4.80 | - | - |
| 2017 | $-243,000 | +70.4% | $-363,000 | $-0.04 | - | - |
| 2016 | $-820,000 | +90.1% | -$1M | $-0.14 | - | - |
See OKYO's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs OKYO Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare OKYO vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonOKYO — Frequently Asked Questions
Quick answers to the most common questions about buying OKYO stock.
Is OKYO growing earnings?
OKYO TTM EPS: $-0.12. Net income: $-5M. Earnings growth: N/A.
What are OKYO's profit margins?
OKYO Pharma Limited net margin is N/A, with operating margin at N/A. Below-average margins reflect competitive or cost pressures.
How consistent are OKYO's earnings?
OKYO earnings data spans 2008-2025. The current earnings trend is N/A YoY. Historical data enables comparison across business cycles.